Results 341 to 350 of about 214,982 (356)

Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120

Nature Medicine, 2005
Akira Hirasawa, Tetsuya Adachi, Yukihiko Sugimoto   +2 more
exaly  

GLUCAGON AND THE HEART

The Lancet, 1970
openaire   +3 more sources

Glucagon, glucagon-like peptide and secretin

British Journal of Pharmacology, 2006
Alistair Mathie, S P H Alexander, John A. Peters   +2 more
openaire   +2 more sources

Exenatide decreases liver fat content and epicardial adipose tissue in patients with obesity and type 2 diabetes: a prospective randomized clinical trial using magnetic resonance imaging and spectroscopy

Diabetes, Obesity and Metabolism, 2016
Anne Dutour, Frank Kober, Jean-Charles Martin   +2 more
exaly  

GLUCAGON ANTIBODIES

The Lancet, 1965
R, Assan, G, Rosselin, J, Drouet, J, Dolais, G, Tchobroutsky   +4 more
openaire   +2 more sources

Biosynthesis of glucagon

Metabolism, 1976
openaire   +3 more sources

Incretin therapies: highlighting common features and differences in the modes of action of glucagon‐like peptide‐1 receptor agonists and dipeptidyl peptidase‐4 inhibitors

Diabetes, Obesity and Metabolism, 2016
exaly  

Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?

Diabetologia, 2011
exaly  

Glucagon

1975
openaire   +1 more source

Glucagon is the key factor in the development of diabetes

Diabetologia, 2016
exaly